Newsletter volume 4
bb7528 10x CD22 (002)
INSIDE THIS ISSUE


  1. Word of welcome
  2. Congratulations
  3. Fluidigm
  4. Symposium 4
  5. News update
logo
bb4950_1 20x CD138
2. Congratulations
Congratulations are in order for Cecile van Els. As of November 1st 2019, she has been appointed as Professor at the faculty of Veterinary Medicine. Her inauguration is on the 8th of June. Livestream starts at 16.15 www.uu.nl/agenda/oratie-cecile-van-els

We would also like to congratulate Rene Toes who was awarded an ERC Advanced Grant. His project is titled: Target to B-cure.
1. Words of welcome

Dear readers
During these trying times, we hope you and your loved ones are in good health.
We've been in contact with several of you and know that in several institutes research and non- Covid related patient care are starting up again. Robert Huiberts (our Financial Manager) will contact the financials of the partners receiving fundig to discuss costs related to the delay in research activities.
We hope you enjoy this newsletter.
Stay safe


9
<a href="https://www.target-to-b.nl/staff-member/roberto-spada/" rel="noopener" target="_blank">Roberto Spada </a>
3. Fluidigm
Fluidigm has joined the consortium as of the first of december 2019. Fluidigm is committed to empowering the Immunology and Oncology community with Mass Cytometry to interrogate immune cell function and the tissue microenvironment with unprecedented resolution. Mass Cytometry and Imaging Mass Cytometry technologies enable new discoveries in immunological research and immune-mediated therapies by allowing for the interrogation of >40 protein markers simultaneously, both in single cells and in single tissue scans. Fluidigm supports research breakthroughs targeting new biomarkers and pathways or optimizing the effectiveness of an immunotherapy or vaccine. Fluidigm will benefit from the insights into the autoimmune and inflammatory disorders studied in this proposal, enabled from the use of Fluidigm technology. This will widen our visibility in the research areas of immunology, inflammation, and autoimmune disorders. We look forward to collaborate with Fluidigm and welcome them to the consortium. Fluidigm will be represented by Roberto Spada. We will meet him (virtually) on the 23rd of June.
<a href="https://www.target-to-b.nl/staff-member/roberto-spada/" rel="noopener" target="_blank">Roberto Spada </a>
1. Words of welcome

Dear readers
During these trying times, we hope you and your loved ones are in good health.
We've been in contact with several of you and know that in several institutes research and non- Covid related patient care are starting up again. Robert Huiberts (our Financial Manager) will contact the financials of the partners receiving fundig to discuss costs related to the delay in research activities.
We hope you enjoy this newsletter.
Stay safe


9